• Arvato Systems now certified as EMVO official Gateway Provider, paving the way for the exchange of master and serialization data across the EU Hub.
  • Rollout of Arvato CSDB EU update, enabling over 80 customers to record data in European Verification Systems

In line with the EU Falsified Medicines Directive (FMD), from February 9, 2019 prescription drugs may only be sold if the integrity of each package is guaranteed by the allocation of a unique serial number. European Medicines Verification Organisation (EMVO) certification for the Arvato CSDB serialization solution offers Arvato Systems the ability to transfer prescription drug serialization data directly into the European Hub.

Using a pilot customer, the EMVO tested and certified the Arvato CSDB serialization solution connectivity for secure, encrypted transmission of data to the EU Hub. Master and serialization data for each drug were among the information transmitted. Data included the product name, production information and verification data such as the serial number status. The EU Hub serves as the official distribution center, from where the individual National Verification Systems receive their serialization data. This enables national systems to process verification requests from pharmacies and wholesalers.

“EMVO certification for the EU Hub is an important milestone for us and our customers. Secure and seamless data transfer of drug serialization data to the EU Hub means that manufacturers and resellers of pharmaceutical goods are now able to map their prescription drugs processes so as to ensure full compliance with the EU directives by February 9, 2019”, confirms Peter Koop, Vice President Healthcare at Arvato Systems.

All member states of the EU are required to provide a National IT System that enables an end-to-end process within the pharmaceutical sales and distribution chain. Countries connected to the EU Hub with their National Verification Systems are now able to share relevant data.

Über die Arvato Systems GmbH

Global IT specialist Arvato Systems supports major companies through digital transformation. More than 3,000 staff in over 25 locations epitomize in-depth technology expertise, industry knowledge and focus on customer requirements.

In the healthcare segment, Arvato Systems covers the entire end-to-end process chain with its own serialization solutions. These solutions support both individual manufacturing companies and national verification systems. Arvato Systems has been selected as an official service provider by the European Medicines Verification Organisation (EMVO). We rely on our own team of serialization experts, which has already implemented numerous projects in the international environment.

Working as a team, we develop innovative IT solutions, transition our clients into the Cloud, integrate digital processes and take on IT systems operation and support. As a part of the Bertelsmann-owned Arvato network, we have the unique capability to work across the entire value chain. Our business relationships are personal; we work with our clients as partners, so that together we can achieve long-term success. IT.arvato.com

Firmenkontakt und Herausgeber der Meldung:

Arvato Systems GmbH
An der Autobahn 200
33333 Gütersloh
Telefon: +49 (5241) 80-80888
Telefax: +49 (5241) 80-80666
https://www.arvato-systems.de

Ansprechpartner:
Marcus Metzner
Chief Marketing Officer
Telefon: +49 (5241) 80-88242
Fax: +49 (5241) 80-9568
E-Mail: Marcus.Metzner@bertelsmann.de
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.